Cargando…

Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease

BACKGROUND: Hospitalized patients are at an increased risk of developing kidney disease after discharge, often despite the absence of any clinical indicators during hospitalization. Soluble urokinase plasminogen activator receptor (suPAR) is a marker of systemic chronic inflammation that can be meas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iversen, Esben, Kallemose, Thomas, Hornum, Mads, Bengaard, Anne Kathrine, Nehlin, Jan Olof, Rasmussen, Line Jee Hartmann, Sandholdt, Haakon, Tavenier, Juliette, Feldt-Rasmussen, Bo, Andersen, Ove, Eugen-Olsen, Jesper, Houlind, Morten Baltzer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308102/ https://www.ncbi.nlm.nih.gov/pubmed/35892012 http://dx.doi.org/10.1093/ckj/sfac048

Ejemplares similares

Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients
por: Iversen, Esben, et al.
Publicado: (2020)

Utility of suPAR and NGAL for AKI Risk Stratification and Early Optimization of Renal Risk Medications among Older Patients in the Emergency Department
por: Walls, Anne Byriel, et al.
Publicado: (2021)

Machine Learning to Identify Patients at Risk of Inappropriate Dosing for Renal Risk Medications: A Critical Comment on Kaas-Hansen et al [Letter]
por: Houlind, Morten Baltzer, et al.
Publicado: (2022)

Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department
por: Stauning, Marius Ahm, et al.
Publicado: (2021)

Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population
por: Haupt, Thomas H, et al.
Publicado: (2014)

Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
por: Godtfredsen, Nina S., et al.
Publicado: (2018)

Alterations of monocyte NF-κB p65/RelA signaling in a cohort of older medical patients, age-matched controls, and healthy young adults
por: Tavenier, Juliette, et al.
Publicado: (2020)

Estimating Renal Function Following Lung Transplantation
por: Hornum, Mads, et al.
Publicado: (2022)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019)

Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy
por: Schultz, Martin, et al.
Publicado: (2019)

BIOLOGICAL AGING IS ASSOCIATED WITH INCREASED MONOCYTE INFLAMMATORY ACTIVITY IN OLDER ADULTS
por: Tavenier, Juliette, et al.
Publicado: (2019)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2021)

Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2016)

Non-adherence, medication beliefs and symptom burden among patients receiving hemodialysis -a cross-sectional study
por: Mechta Nielsen, Trine, et al.
Publicado: (2023)

Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis
por: Petersen, Jens Emil Vang, et al.
Publicado: (2020)

Comparison of 24‐hour urinary creatinine clearance and estimated glomerular filtration rate based on a panel of filtration markers in patients with chronic kidney disease
por: Iversen, Esben, et al.
Publicado: (2022)

Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation
por: Magnusson, Nils E, et al.
Publicado: (2012)

Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study*
por: Rasmussen, Line J. H., et al.
Publicado: (2018)

Association of soluble urokinase plasminogen activator receptor levels with fibrotic and vascular manifestations in systemic sclerosis
por: Butt, Sheraz, et al.
Publicado: (2021)

Medicines Reconciliation in the Emergency Department: Important Prescribing Discrepancies between the Shared Medication Record and Patients’ Actual Use of Medication
por: Andersen, Tanja Stenholdt, et al.
Publicado: (2022)

Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor
por: Rotbain Curovic, Viktor, et al.
Publicado: (2022)

Clinical value of soluble urokinase type plasminogen activator receptors in chronic kidney disease
por: Ahmed, Reem M., et al.
Publicado: (2019)

Risk of Malnutrition upon Admission and after Discharge in Acutely Admitted Older Medical Patients: A Prospective Observational Study
por: Andersen, Aino Leegaard, et al.
Publicado: (2021)

A Collaborative Medication Review Including Deprescribing for Older Patients in an Emergency Department: A Longitudinal Feasibility Study
por: Houlind, Morten Baltzer, et al.
Publicado: (2020)

Cardiovascular mortality in patients with advanced chronic kidney disease with and without diabetes: a nationwide cohort study
por: Kofod, Dea Haagensen, et al.
Publicado: (2023)

Dysphagia Prevalence, Time Course, and Association with Probable Sarcopenia, Inactivity, Malnutrition, and Disease Status in Older Patients Admitted to an Emergency Department: A Secondary Analysis of Cohort Study Data
por: Hansen, Tina, et al.
Publicado: (2021)

Optimization of Nutrition And Medication (OptiNAM) for acutely admitted older patients: protocol for a randomized single-blinded controlled trial
por: Andersen, Aino L., et al.
Publicado: (2021)

Soluble urokinase-type plasminogen activator receptor in sickle cell disease–associated chronic kidney disease
por: Afangbedji, Nowah, et al.
Publicado: (2022)

Soluble Urokinase Plasminogen Activator Receptor as a Marker for Use of Antidepressants
por: Haastrup, Eva, et al.
Publicado: (2014)

Longitudinal course of GDF15 levels before acute hospitalization and death in the general population
por: Tavenier, Juliette, et al.
Publicado: (2021)

Practices and pitfalls in medication adherence in hemodialysis settings – a focus-group study of health care professionals
por: Mechta Nielsen, Trine, et al.
Publicado: (2021)

Micro‐ and macrovascular complications and risk factors for foot ulceration and amputation in individuals receiving dialysis with and without diabetes
por: Kofod, Dea Haagensen, et al.
Publicado: (2021)

Differences in Kidney Function Estimates Based on Creatinine and/or Cystatin C in Non-Traumatic Amputation Patients and Their Impact on Drug Prescribing
por: Aakjær, Mia, et al.
Publicado: (2019)

In silico docking of urokinase plasminogen activator and integrins
por: Degryse, Bernard, et al.
Publicado: (2008)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022)

A Collaborative Deprescribing Intervention in a Subacute Medical Outpatient Clinic: A Pilot Randomized Controlled Trial
por: Aharaz, Anissa, et al.
Publicado: (2021)

Plasma Soluble Urokinase Plasminogen Activator Receptor in Children with Urinary Tract Infection
por: Wittenhagen, Per, et al.
Publicado: (2011)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Soluble Urokinase‐Type Plasminogen Activator Receptor, Changes of 24‐Hour Blood Pressure, and Progression of Chronic Kidney Disease
por: Jhee, Jong Hyun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_via95vtckj0lfn4l29uvq69s9r